Adriamycin‐loaded exosome with anti‐CD20 aptamers selectively suppresses human CD20+ melanoma stem cells

BACKGROUND: Targeting CD20+ melanoma cancer stem cells (CSCs) subset is essential for treating melanoma. Anti‐CD20 aptamer‐modified exosomes (ACEXO) loaded with Adriamycin could be a therapeutic strategy for targeting CSCs. MATERIALS AND METHODS: Exosomes loaded with Adriamycin were modified with an...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Hairong, Jiang, Yuxia, Li, Xia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838758/
https://www.ncbi.nlm.nih.gov/pubmed/36704890
http://dx.doi.org/10.1111/srt.13259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838758/
https://www.ncbi.nlm.nih.gov/pubmed/36704890
http://dx.doi.org/10.1111/srt.13259

Ejemplares similares